BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4867872)

  • 1. Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone.
    Jasinski DR; Martin WR; Sapira JD
    Clin Pharmacol Ther; 1968; 9(2):215-22. PubMed ID: 4867872
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of morphine, nalorphine, cyclazocine, and naloxone on the flexor reflex.
    McClane TK; Martin WR
    Int J Neuropharmacol; 1967 Mar; 6(2):89-98. PubMed ID: 5232358
    [No Abstract]   [Full Text] [Related]  

  • 3. Assaying narcotic-antagonist drugs for analgesic activity in rhesus monkeys.
    Malis JL; Gluckman MI
    Adv Biochem Psychopharmacol; 1973; 8(0):225-33. PubMed ID: 4211815
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of morphine, nalorphine, naloxone, pentazocine, cyclazocine and oxotremorine on the synthesis and release of acetylcholine by mouse cerebral cortex slices in vitro.
    Howes JF; Harris LS; Dewey WL
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):267-76. PubMed ID: 5453231
    [No Abstract]   [Full Text] [Related]  

  • 5. Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI).
    Haertzen CA
    Psychopharmacologia; 1970; 18(4):366-77. PubMed ID: 4923522
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).
    Martin WR; Fraser HF; Gorodetzky CW; Rosenberg DE
    J Pharmacol Exp Ther; 1965 Dec; 150(3):426-36. PubMed ID: 5322320
    [No Abstract]   [Full Text] [Related]  

  • 7. The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone).
    Jasinski DR; Martin WR; Haertzen CA
    J Pharmacol Exp Ther; 1967 Aug; 157(2):420-6. PubMed ID: 6039832
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of narcotic antagonists on the pupil diameter of nonaddicts.
    ELLIOT HW; WAY EL
    Clin Pharmacol Ther; 1961; 2():713-21. PubMed ID: 13889927
    [No Abstract]   [Full Text] [Related]  

  • 9. Assays of antagonistic activity of narcotic antagonists in man.
    Gorodetzky CW
    Adv Biochem Psychopharmacol; 1973; 8(0):291-7. PubMed ID: 4604130
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of the action of naloxone (Narcan) and nalorphine in man.
    Aronski A; Kübler A; Majda A; Jakubaszko J
    Anaesth Resusc Intensive Ther; 1975; 3(3):221-30. PubMed ID: 1217693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative studies on the antagonism by naloxone of some narcotic and narcotic-antagonist analgesics.
    Smits SE; Takemori AE
    Br J Pharmacol; 1970 Jul; 39(3):627-38. PubMed ID: 5472208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcotic-antagonist assay procedures in dogs.
    Dewey WL
    Adv Biochem Psychopharmacol; 1973; 8(0):263-72. PubMed ID: 4794991
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of narcotic analgetics and narcotic antagonists on respiration.
    FOLDES FF; KOUKAL LR; ZEEDICK FJ
    Am J Med Sci; 1957 Feb; 233(2):153-61. PubMed ID: 13394592
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of (minus)-3-hydroxy-N-cyclopropylmethylmorphinan (cyclorphan).
    Harris LS; Pierson AK; Dembinski JR; Dewey WL
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):112-26. PubMed ID: 4382141
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of writhing by narcotic antagonists.
    Pearl J; Harris LS
    J Pharmacol Exp Ther; 1966 Nov; 154(2):319-23. PubMed ID: 4380744
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridged amino tetralins.
    Freed ME; Potoski JR; Freed EH; Gluckman MI; Malis JL
    Adv Biochem Psychopharmacol; 1973; 8(0):137-44. PubMed ID: 4211844
    [No Abstract]   [Full Text] [Related]  

  • 18. ANALGESIC EFFECTS IN MONKEYS OF MORPHINE, NALORPHINE, AND A BENZOMORPHAN NARCOTIC ANTAGONIST.
    WEISS B; LATIES VG
    J Pharmacol Exp Ther; 1964 Feb; 143():169-73. PubMed ID: 14163989
    [No Abstract]   [Full Text] [Related]  

  • 19. Assays for narcotic antagonist activity in rodents.
    Pierson AK
    Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of different narcotic antagonists].
    Foldes FF
    Arch Toxikol; 1968; 24(1):51-5. PubMed ID: 4884137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.